List of works - Edith T Zemanick

Advances in the diagnosis and treatment of cystic fibrosis.

scientific article published on 03 May 2014

Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis.

scientific article

Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation

scientific article published on 01 June 2020

Airway microbiota across age and disease spectrum in cystic fibrosis

scientific article

Alterations of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis. Cystic Fibrosis Transmembrane Conductance Regulator and Antibiotic Effects

scientific article published in March 2016

Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices

scientific article published on 31 October 2019

Application of multiple event analysis as an alternative approach to studying pulmonary exacerbations as an outcome measure

scientific article published on 11 January 2019

Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods

scientific article

Bacterial Community Variability: Outliers May Be Leading Us Astray

scientific article published on 01 December 2019

Bacterial Signatures of Paediatric Respiratory Disease: An Individual Participant Data Meta-Analysis

scientific article published on 23 December 2021

Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis

scientific article published on 10 December 2019

Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation

scientific article published on 01 February 2020

Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis

scientific article published on 22 February 2019

Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis

scientific article published on 18 June 2018

Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients

scientific article published on 28 April 2015

Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic Fibrosis

scientific article published on 23 March 2016

Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis.

scientific article

Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor

scientific article published on 10 August 2018

Cystic Fibrosis: Microbiology and Host Response

scientific article

Cystic fibrosis transmembrane conductance regulator and pseudomonas

scientific article published in April 2014

Cystic fibrosis: a model system for precision medicine.

scientific article published on 30 March 2016

Editorial Commentary: Pseudomonas aeruginosa Eradication: How Do We Measure Success?

scientific article published on 13 May 2015

Entering the era of highly effective CFTR modulator therapy

scientific article published on 31 October 2019

Highlights from the 2015 North American Cystic Fibrosis Conference

scientific article published on 13 April 2016

Highlights from the 2016 North American Cystic Fibrosis Conference.

scientific article published on 11 July 2017

Highlights from the 2017 North American Cystic Fibrosis Conference

scientific article published on 16 April 2018

Highlights from the 2018 North American cystic fibrosis conference

scientific article published on 15 May 2019

Impact of Antibiotics on the Lung Microbiome and Lung Function in Children with Cystic Fibrosis One Year after Hospitalization for an Initial Pulmonary Exacerbation

scientific article published in 2022

Impact of enzymatic digestion on bacterial community composition in CF airway samples

scientific article

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

scientific article

Influence of Acid Blockade on the Aerodigestive Tract Microbiome in Children With Cystic Fibrosis

scientific article published on 02 December 2020

Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis

scientific article published on 6 February 2015

Lessons from the lower airway microbiome in early CF

scientific article published on 27 April 2017

Luminescent Nanosensors for Ratiometric Monitoring of Three-Dimensional Oxygen Gradients in Laboratory and Clinical Pseudomonas aeruginosa Biofilms

scientific article published on 01 October 2019

Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy

scientific article

Microbes in bronchiectasis: the forest or the trees?

scientific article published in May 2013

Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.

scientific article published on 15 November 2016

Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis

scientific article published on 25 January 2016

Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

scientific article

Nanodiagnostics to monitor biofilm oxygen metabolism for antibiotic susceptibility testing

scientific article published on 28 April 2020

Narrowing in on early cystic fibrosis lung disease.

scientific article published in November 2014

Newborn screening for cystic fibrosis

scientific article published on 01 June 2012

Novel Application of Aptamer Proteomic Analysis in Cystic Fibrosis Bronchoalveolar Lavage Fluid

scientific article published on 03 January 2019

On the Use of Diversity Measures in Longitudinal Sequencing Studies of Microbial Communities.

scientific article published on 22 May 2018

Oral antibiotic prescribing patterns for treatment of pulmonary exacerbations in two large pediatric CF centers

scientific article published on 24 September 2020

Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR.

scientific article published on 13 February 2017

Prevention of chronic infection with Pseudomonas aeruginosa infection in cystic fibrosis

scientific article published on 01 November 2019

Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.

scientific article published on 11 December 2017

Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures

scientific article

Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens

scientific article

Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis

scientific article

Sputum induction improves detection of pathogens in children with cystic fibrosis.

scientific article published on 7 January 2015

The airway microbiome in cystic fibrosis and implications for treatment

scientific article published in June 2011

Unraveling the CFTR Function-Phenotype Connection for Precision Treatment in Cystic Fibrosis

scientific article published on 01 May 2019

Volatile molecules from bronchoalveolar lavage fluid can 'rule-in' Pseudomonas aeruginosa and 'rule-out' Staphylococcus aureus infections in cystic fibrosis patients.

scientific article published on 16 January 2018

List of works by Edith T Zemanick

Advances in the diagnosis and treatment of cystic fibrosis.

Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis.

Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation

Airway microbiota across age and disease spectrum in cystic fibrosis

Alterations of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis. Cystic Fibrosis Transmembrane Conductance Regulator and Antibiotic Effects

Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices

Application of multiple event analysis as an alternative approach to studying pulmonary exacerbations as an outcome measure

Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods

Bacterial Community Variability: Outliers May Be Leading Us Astray

Bacterial Signatures of Paediatric Respiratory Disease: An Individual Participant Data Meta-Analysis

Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis

Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation

Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis

Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis

Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients

Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic Fibrosis

Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis.

Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor

Cystic Fibrosis: Microbiology and Host Response

Cystic fibrosis transmembrane conductance regulator and pseudomonas

Cystic fibrosis: a model system for precision medicine.

Editorial Commentary: Pseudomonas aeruginosa Eradication: How Do We Measure Success?

Entering the era of highly effective CFTR modulator therapy

Highlights from the 2015 North American Cystic Fibrosis Conference

Highlights from the 2016 North American Cystic Fibrosis Conference.

Highlights from the 2017 North American Cystic Fibrosis Conference

Highlights from the 2018 North American cystic fibrosis conference

Impact of Antibiotics on the Lung Microbiome and Lung Function in Children with Cystic Fibrosis One Year after Hospitalization for an Initial Pulmonary Exacerbation

Impact of enzymatic digestion on bacterial community composition in CF airway samples

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

Influence of Acid Blockade on the Aerodigestive Tract Microbiome in Children With Cystic Fibrosis

Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis

Lessons from the lower airway microbiome in early CF

Luminescent Nanosensors for Ratiometric Monitoring of Three-Dimensional Oxygen Gradients in Laboratory and Clinical Pseudomonas aeruginosa Biofilms

Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy

Microbes in bronchiectasis: the forest or the trees?

Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.

Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis

Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

Nanodiagnostics to monitor biofilm oxygen metabolism for antibiotic susceptibility testing

Narrowing in on early cystic fibrosis lung disease.

Newborn screening for cystic fibrosis

Novel Application of Aptamer Proteomic Analysis in Cystic Fibrosis Bronchoalveolar Lavage Fluid

On the Use of Diversity Measures in Longitudinal Sequencing Studies of Microbial Communities.

Oral antibiotic prescribing patterns for treatment of pulmonary exacerbations in two large pediatric CF centers

Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR.

Prevention of chronic infection with Pseudomonas aeruginosa infection in cystic fibrosis

Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.

Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures

Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens

Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis

Sputum induction improves detection of pathogens in children with cystic fibrosis.

The airway microbiome in cystic fibrosis and implications for treatment

Unraveling the CFTR Function-Phenotype Connection for Precision Treatment in Cystic Fibrosis

Volatile molecules from bronchoalveolar lavage fluid can 'rule-in' Pseudomonas aeruginosa and 'rule-out' Staphylococcus aureus infections in cystic fibrosis patients.